Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AngioDynamics Foresees New Laser Sales Opportunities With Sotradecol

This article was originally published in The Pink Sheet Daily

Executive Summary

Angiodynamics will market its Sotradecol drug for the treatment of small, uncomplicated varicose veins with its VenaCure laser ablation system for larger varicose veins.

You may also be interested in...



Bioniche Pharma Wrongly Guarantees Safety Of Sotradecol, Ad Division Warning Letter Says

A company brochure for the varicose vein therapy implies FDA approval “guarantees” safety.

Cosmetic Microbeads A Drop In The Bucket Compared With Possible EU Microplastic Restriction Impacts

Microplastic-infused leave-on cosmetics targeted by the EU’s proposed restriction are numerous and complexly formulated, and there currently are no viable replacement ingredients, according to Cosmetics Europe. Eliminating plastic microbeads from rinse-off products was a far simpler undertaking, but it still took more than four years and resulted in the discontinuation of roughly half of affected formulations. 

Topics

UsernamePublicRestriction

Register

ID1132028

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel